Molecular testing services
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36C24526D0034
- Awardee
-
Veracyte, Inc. UEI JS7GBP6LCMN6
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 1 $82,550 obligated
Award facts
- Combined order value
-
- $82,550 Current, with exercised options
- $412,750 Potential, with all options
- Last date to order 11% complete
- IDV ceiling 20% used
- $412,750.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 5 awarded a single-award indefinite-delivery contract to Veracyte, Inc. for molecular testing services with a contract ceiling of $412,750.00 and an award date of March 23, 2026.
Place of performance includes Veterans Integrated Service Network 5 facilities and subordinate VA healthcare locations. The contract extends through March 22, 2031, providing a five-year period for the delivery of specialized genomic testing services.
The IDIQ procures molecular diagnostic testing services, including proprietary genomic sequencing classifiers and reference laboratory testing to support precision medicine applications across the VA healthcare system. The vehicle operates under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), enabling task orders to be issued to support VA clinical operations.
Veracyte, Inc. is a medical diagnostic company headquartered in South San Francisco, California, specializing in advanced genomic testing services including the Decipher Prostate Cancer Test and Afirma Genomic Sequencing Classifier for thyroid nodule assessment. The company has established an extensive federal contract portfolio delivering specialized genomic testing services across multiple Department of Veterans Affairs networks, the Defense Health Agency, and the Indian Health Service through multiple indefinite-delivery vehicles and blanket purchase agreements.
This is a single-award contract with no set-aside designation, reflecting the proprietary and specialized nature of Veracyte's diagnostic capabilities. The contract supports the government's precision medicine and personalized cancer care initiatives within the VA healthcare system.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Molecular testing | Veterans Integrated Service Network 5 (VHA) | $82,550 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24526D0034?
36C24526D0034 was awarded to Veracyte, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 23, 2026.
How much is contract 36C24526D0034 worth?
Orders under 36C24526D0034 have obligated $82,550. Their combined potential value, with all options, is $412,750. 36C24526D0034's own ceiling is $412,750.
How many orders have been placed under contract 36C24526D0034?
1 order has been placed under 36C24526D0034, the latest on March 23, 2026.
Who can order from contract 36C24526D0034?
36C24526D0034 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36C24526D0034 competed?
The extent of competition for 36C24526D0034 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV